The estrogen receptor α-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice: potential molecular mechanisms

in Journal of Endocrinology
Authors:
L LundholmDepartment of Biosciences and Nutrition, Karolinska Institute, Huddinge, Sweden

Search for other papers by L Lundholm in
Current site
Google Scholar
PubMedClose
,
G BryzgalovaDepartment of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by G Bryzgalova in
Current site
Google Scholar
PubMedClose
,
H GaoDepartment of Biosciences and Nutrition, Karolinska Institute, Huddinge, Sweden

Search for other papers by H Gao in
Current site
Google Scholar
PubMedClose
,
N PortwoodDepartment of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by N Portwood in
Current site
Google Scholar
PubMedClose
,
S FältDepartment of Biosciences and Nutrition, Karolinska Institute, Huddinge, Sweden

Search for other papers by S Fält in
Current site
Google Scholar
PubMedClose
,
K D BerndtDepartment of Biosciences and Nutrition, Karolinska Institute, Huddinge, Sweden

Search for other papers by K D Berndt in
Current site
Google Scholar
PubMedClose
,
A DickerDepartment of Medicine, Karolinska Institute, Karolinska University Hospital, Huddinge, Sweden

Search for other papers by A Dicker in
Current site
Google Scholar
PubMedClose
,
D GaluskaDepartment of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Search for other papers by D Galuska in
Current site
Google Scholar
PubMedClose
,
J R ZierathDepartment of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Search for other papers by J R Zierath in
Current site
Google Scholar
PubMedClose
,
J-Å GustafssonDepartment of Biosciences and Nutrition, Karolinska Institute, Huddinge, Sweden

Search for other papers by J-Å Gustafsson in
Current site
Google Scholar
PubMedClose
,
S EfendicDepartment of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by S Efendic in
Current site
Google Scholar
PubMedClose
,
K Dahlman-WrightDepartment of Biosciences and Nutrition, Karolinska Institute, Huddinge, Sweden

Search for other papers by K Dahlman-Wright in
Current site
Google Scholar
PubMedClose
, and
A KhanDepartment of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden

Search for other papers by A Khan in
Current site
Google Scholar
PubMedClose
View More View Less

Correspondence should be addressed to L Lundholm: lovisa.lundholm@su.se
DOI:
https://doi.org/10.1530/JOE-08-0192e
Volume/Issue:
Volume 243: Issue 2
Article Type:
Correction
Page Range:
X1
Online Publication Date:
Nov 2019
Copyright:
© 2019 Society for Endocrinology 2019
A RELATED ARTICLE IS AVAILABLE
Free access

The authors and journal apologise for an error in the above paper, which appeared in volume 199 part 2, pages 275–286. The error relates to Fig. 10, given on page 283. The corrected composite figure for Fig. 10 is given in full below:

Figure 10
Figure 10

Western blot analysis of Stat3, phosphorylated Stat3 on Tyr705 (Stat3P), and glucose-6-phosphatase (G6p) protein in liver of ob/ob mice treated with vehicle or PPT for 30 days (n = 5 mice/group). (A) Immunoblots for each respective protein showing the results for individual liver samples from the vehicle-treated or PPT-treated mice. (B) Mean ± s.e.m. relative abundance for each respective protein in liver of vehicle-treated (open bar) or PPT-treated (filled bar) ob/ob mice (n = 5 mice/group). P = 0.07, **P < 0.01 for PPT-treated versus vehicle-treated ob/ob mice.

Citation: Journal of Endocrinology 243, 2; 10.1530/JOE-08-0192e

Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.

The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.

More information is on the Reasons to publish page.

Sept 2018 onwards Past Year Past 30 Days
Full Text Views 129 129 9
PDF Downloads 54 54 0

 

  • Collapse
  • Expand
Print ISSN:
0022-0795
Online ISSN:
1479-6805
Copyright:
© 2019 Society for Endocrinology 2019
Article Type:
Correction
Print Publication Date:
01 Nov 2019
Online Publication Date:
Nov 2019
  • Figure 10
    View in gallery
    Figure 10

    Western blot analysis of Stat3, phosphorylated Stat3 on Tyr705 (Stat3P), and glucose-6-phosphatase (G6p) protein in liver of ob/ob mice treated with vehicle or PPT for 30 days (n = 5 mice/group). (A) Immunoblots for each respective protein showing the results for individual liver samples from the vehicle-treated or PPT-treated mice. (B) Mean ± s.e.m. relative abundance for each respective protein in liver of vehicle-treated (open bar) or PPT-treated (filled bar) ob/ob mice (n = 5 mice/group). P = 0.07, **P < 0.01 for PPT-treated versus vehicle-treated ob/ob mice.

Figure 10

Western blot analysis of Stat3, phosphorylated Stat3 on Tyr705 (Stat3P), and glucose-6-phosphatase (G6p) protein in liver of ob/ob mice treated with vehicle or PPT for 30 days (n = 5 mice/group). (A) Immunoblots for each respective protein showing the results for individual liver samples from the vehicle-treated or PPT-treated mice. (B) Mean ± s.e.m. relative abundance for each respective protein in liver of vehicle-treated (open bar) or PPT-treated (filled bar) ob/ob mice (n = 5 mice/group). P = 0.07, **P < 0.01 for PPT-treated versus vehicle-treated ob/ob mice.